##gff-version 3
##sequence-region Q9Y3P8 1 196
Q9Y3P8	UniProtKB	Signal peptide	1	24	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y3P8	UniProtKB	Chain	25	196	.	.	.	ID=PRO_0000045152;Note=Signaling threshold-regulating transmembrane adapter 1	
Q9Y3P8	UniProtKB	Topological domain	25	40	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y3P8	UniProtKB	Transmembrane	41	61	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y3P8	UniProtKB	Topological domain	62	196	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y3P8	UniProtKB	Region	90	93	.	.	.	Note=Interaction with GRB2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Region	146	151	.	.	.	Note=Interaction with PTPN11	
Q9Y3P8	UniProtKB	Region	169	172	.	.	.	Note=Interaction with CSK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Region	188	191	.	.	.	Note=Interaction with GRB2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Modified residue	80	80	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:15144186;Dbxref=PMID:15144186	
Q9Y3P8	UniProtKB	Modified residue	83	83	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q5M869	
Q9Y3P8	UniProtKB	Modified residue	90	90	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:15144186,ECO:0000269|PubMed:11433379;Dbxref=PMID:15144186,PMID:11433379	
Q9Y3P8	UniProtKB	Modified residue	102	102	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q9Y3P8	UniProtKB	Modified residue	127	127	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Modified residue	144	144	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:15144186,ECO:0000244|PubMed:19690332;Dbxref=PMID:15144186,PMID:19690332	
Q9Y3P8	UniProtKB	Modified residue	148	148	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000269|PubMed:10209036,ECO:0000269|PubMed:11433379;Dbxref=PMID:19690332,PMID:10209036,PMID:11433379	
Q9Y3P8	UniProtKB	Modified residue	169	169	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:15144186,ECO:0000244|PubMed:19690332;Dbxref=PMID:15144186,PMID:19690332	
Q9Y3P8	UniProtKB	Modified residue	188	188	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:15144186,ECO:0000244|PubMed:19690332,ECO:0000269|PubMed:11433379;Dbxref=PMID:15144186,PMID:19690332,PMID:11433379	
Q9Y3P8	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10209036;Dbxref=PMID:10209036	
Q9Y3P8	UniProtKB	Disulfide bond	27	27	.	.	.	Note=Interchain;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y3P8	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Abolishes glycosylation. N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10209036;Dbxref=PMID:10209036	
Q9Y3P8	UniProtKB	Mutagenesis	90	90	.	.	.	Note=Reduces interaction with GRB2. Abolishes interaction with GRB2%3B when associated with F-188. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No effect on interaction with PTPN11 or GRB2. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Reduces interaction with PTPN11%2C no effect on inhibition of NF-AT activation. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10209036,ECO:0000269|PubMed:11433379;Dbxref=PMID:10209036,PMID:11433379	
Q9Y3P8	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Abolishes interaction with CSK and impairs inhibition of NF-AT activation. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
Q9Y3P8	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Reduces interaction with GRB2. Abolishes interaction with GRB2%3B when associated with F-90. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11433379;Dbxref=PMID:11433379	
